v3.25.3
S-K 1602(a)(3) Forepart, Sponsor Compensation
Dec. 04, 2025
USD ($)
$ / shares
shares
Spac Offering Forepart Sponsor Compensation Line Items  
Price Paid or to be Paid for Securities, Total Amount $ 10,000
Sponsor [Member]  
Spac Offering Forepart Sponsor Compensation Line Items  
Securities Issued or to be Issued, Shares | shares 500,000
Sponsor [Member] | Private Units [Member]  
Spac Offering Forepart Sponsor Compensation Line Items  
Securities Issued or to be Issued, Shares | shares 233,000
Price Paid or to be Paid for Securities, Total Amount $ 2,330,000
Sponsor [Member] | Over Allotments Option [Member]  
Spac Offering Forepart Sponsor Compensation Line Items  
Securities Issued or to be Issued, Shares | shares 251,750
Price Paid or to be Paid for Securities, Total Amount $ 2,517,500
Sponsor [Member] | Units [Member]  
Spac Offering Forepart Sponsor Compensation Line Items  
Price Paid or to be Paid for Securities, Per Share | $ / shares $ 10.00
Sponsor [Member] | Ordinary Shares [Member]  
Spac Offering Forepart Sponsor Compensation Line Items  
Securities Issued or to be Issued, Shares | shares 3,833,333
Sponsor [Member] | Class B Ordinary Shares [Member]  
Spac Offering Forepart Sponsor Compensation Line Items  
Price Paid or to be Paid for Securities, Total Amount $ 25,000
Future Wealth Capital Corp [Member] | Ordinary Shares [Member]  
Spac Offering Forepart Sponsor Compensation Line Items  
Securities Issued or to be Issued, Shares | shares 3,333,333 [1]
Price Paid or to be Paid for Securities, Total Amount $ 25,000
Future Wealth Capital Corp [Member] | Private Placement Units [Member]  
Spac Offering Forepart Sponsor Compensation Line Items  
Securities Issued or to be Issued, Shares | shares 233,000
Price Paid or to be Paid for Securities, Total Amount $ 2,330,000
Future Wealth Capital Corp [Member] | Loan [Member]  
Spac Offering Forepart Sponsor Compensation Line Items  
Price Paid or to be Paid for Securities, Total Amount $ 600,000
[1] Assumes the full surrender and forfeiture of 500,000 founder shares and no exercise of the underwriters’ over-allotment option.